Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT00357669
Brief Summary:
The study will compare the efficacy and safety of brivaracetam with placebo in patients with Unverricht-Lundborg disease.
Study:
NCT00357669
Study Brief:
Protocol Section:
NCT00357669